Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn.
How we work:
- PIONEER: We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines.
- COLLABORATE: We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine.
- BELONG: We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard.
How you’ll make an impact:
Kymera is seeking a Senior/Executive Director, AI Strategy & Applications to serve as the company's first dedicated AI leader. Reporting to the VP, Information Technology, this hands-on builder will work collaboratively with Kymera’s CEO and Executive Team to define Kymera's enterprise AI strategy and lead its execution. The person will own the selection and governance of AI platforms, and partner across Research, Clinical Development, Regulatory/CMC, and G&A to turn scientific and business challenges into working AI solutions.
- Define and maintain Kymera's enterprise AI strategy and multi-year roadmap, aligned to clinical and scientific priorities
- Prototype, build, and ship AI-powered solutions, both progressing and adding to multiple existing initiatives, to meet urgent business needs
- Own evaluation, selection, and administration of AI platforms (LLM tools, AI-assisted coding tools, scientific AI applications) across the enterprise, partnering with leadership to design and implement AI strategy for their functions.
- Establish and lead an AI governance function, partnering with Information Security on data privacy, acceptable use, and vendor risk policies
- Manage the AI vendor landscape and take ownership of deliverables from external AI engagements, determining what to operationalize or extend
- Champion AI adoption through education and enablement, partnering with People & Culture on training programs and AI-fluency hiring criteria
- Own Kymera's Answer Engine Optimization (AEO) / Generative Engine Optimization (GEO) strategy, ensuring AI platforms accurately represent Kymera's science and market position
- Build trusted relationships with functional leaders as a credible advisor on AI capabilities and limitations, from bench scientists to the C-suite
Skills and experience you’ll bring:
- Experienced in biotech/pharma, with working knowledge of drug discovery, clinical development, regulatory, or CMC processes
- Hands-on with modern AI/LLM platforms (e.g., OpenAI, Anthropic, Azure OpenAI), building solutions via APIs, prompt engineering, and agentic frameworks
- A strong software developer able to independently build and ship AI-powered applications
- Skilled at translating complex business requirements into practical AI solutions
- Experienced managing vendor evaluations and enterprise AI platform deployments
- An excellent communicator, equally credible with technical and non-technical stakeholders
- Preferred: experience in clinical-stage/growth-stage biotech, AI governance in a regulated environment, AEO/GEO familiarity, and comfort operating in a high-autonomy, fast-moving environment
Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to race, color, religion, creed, gender, national origin, age, disability, veteran status, pregnancy, sex, marital status, gender expression or identity, genetic information, sexual orientation, citizenship, or any other legally protected class.
Compensation
- Kymera offers a competitive compensation package that recognizes both results and capabilities through market-based, performance-driven pay.
- The anticipated base salary range for this role is $235,000 – $335,000, with eligibility for annual bonus, equity participation, and comprehensive benefits.
- Actual salary is based on a holistic evaluation of the specific role/level as well as each candidate’s depth of experience and the capabilities they bring to the position.
Skills Required
- Working knowledge of drug discovery, clinical development, regulatory, or CMC processes.
- Hands-on experience with modern AI/LLM platforms (OpenAI, Anthropic, Azure OpenAI), building solutions via APIs, prompt engineering, and agentic frameworks.
- Ability to prototype, build, and ship AI-powered applications as a strong software developer.
- Skilled at translating complex business requirements into practical AI solutions.
- Experience managing vendor evaluations and enterprise AI platform deployments.
- Excellent communicator, credible with technical and non-technical stakeholders.
- Experience in clinical-stage or growth-stage biotech.
- Experience with AI governance in a regulated environment.
- Familiarity with Answer Engine Optimization (AEO) / Generative Engine Optimization (GEO).
- Comfort operating in a high-autonomy, fast-moving environment.
Kymera Therapeutics Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Kymera Therapeutics and has not been reviewed or approved by Kymera Therapeutics.
-
Fair & Transparent Compensation — Pay is considered market‑competitive for core scientific and leadership roles, with clearly posted ranges visible for U.S. openings. Feedback suggests strong base pay aligns with comments about high salary and good pay.
-
Equity Value & Accessibility — Employees are eligible to participate in broad‑based equity programs, including an equity incentive plan and an ESPP. Feedback suggests this ownership opportunity can meaningfully augment total compensation in a growth‑focused setting.
-
Leave & Time Off Breadth — Company‑wide office shutdowns, standard PTO, and summer schedules are promoted to help people unplug. Feedback suggests these practices contribute to a well‑rounded time‑off offering.
Kymera Therapeutics Insights
What We Do
Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight cancer. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years








